CTSD and Alzheimer disease: ELISA results showed that the AD group had significantly lower plasma cathepsin D levels (1836 ± 1744 pg/mL) than controls (4219 ± 3011 pg/mL) (p = 0.0266, Dunn’s multiple comparisons test, Figure 5).